Xtant Medical Holdings (XTNT) Shareholder's Equity Growth (5y) (2015 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Xtant Medical Holdings | 64.46 Mn | 47.14 Mn | 17.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 28.55% |
| Sep 30, 2025 | 0.98% |
| Jun 30, 2025 | 24.86% |
| Mar 31, 2025 | 24.11% |
| Dec 31, 2024 | 24.34% |
| Sep 30, 2024 | 25.12% |
| Jun 30, 2024 | 25.36% |
| Mar 31, 2024 | 26.33% |
| Dec 31, 2023 | 25.98% |
| Sep 30, 2023 | 34.00% |
| Jun 30, 2023 | 23.89% |
| Mar 31, 2023 | 15.95% |
| Dec 31, 2022 | 20.89% |
| Sep 30, 2022 | 25.26% |
| Jun 30, 2022 | 26.85% |
| Mar 31, 2022 | 34.38% |
| Dec 31, 2021 | 44.80% |
| Sep 30, 2021 | 53.06% |
| Jun 30, 2021 | 134.07% |
| Mar 31, 2021 | 58.26% |
| Dec 31, 2020 | 10.33% |
| Sep 30, 2020 | 80.10% |
| Jun 30, 2020 | -31.65% |
| Mar 31, 2020 | -34.72% |
| Dec 31, 2019 | -41.56% |
| Jun 30, 2019 | -38.85% |
| Mar 31, 2019 | -42.94% |
| Dec 31, 2018 | -62.68% |
| Sep 30, 2018 | 85.38% |
| Jun 30, 2018 | 25.29% |
| Mar 31, 2018 | 42.49% |
| Dec 31, 2017 | -73.82% |
| Sep 30, 2017 | -40.72% |
| Jun 30, 2017 | -32.99% |
| Mar 31, 2017 | -27.49% |
| Dec 31, 2016 | -26.86% |
| Sep 30, 2016 | -20.94% |
| Jun 30, 2016 | -15.50% |
| Dec 31, 2015 | 74.83% |